Dendrimer-drug therapy could help calm neuroinflammation

Chronic inflammation plays a role in neurodegenerative diseases, such as cerebral palsy. Branched, nanoscale polymer structures called dendrimers, when combined with drugs, could deliver therapies to quell inflammation, leading to functional improvements in neurodegenerative diseases. Via dendrimers, drugs could even be transported across the restrictive blood-brain barrier.

Johns Hopkins University Professor Kannan Rangaramanujan will present “Dendrimer-based nanotherapeutics for the treatment of neuroinflammation” on Monday, January 30 at 1:30 p.m. in the Talbot Library (Traylor 709) at the Johns Hopkins University medical campus. His presentation will be broadcast simultaneously to the Homewood campus in the Rome Room (Clark 110), as well as live webcast.

Read an abstract of Rangarmanujan’s talk.

Professor Rangaramanujan is a faculty member in the Center for Nanomedicine in the Department of Ophthalmology/Wilmer Eye Institute at the Johns Hopkins School of Medicine. He comes to Hopkins from Wayne State University in Detroit, where he was in the Department of Chemical Engineering and Materials Science.

This talk is part of the Biomedical Engineering Seminar Series. Future seminar topics may be found on the BME seminar calendar.

not here